Comprehensive analysis of FDA warning letters, compliance actions, and Form 483 citations —
action type breakdowns, top companies, geographic distribution, and most-cited CFR violations.
Sourced from official FDA compliance databases. Data Sources below shows when each was last refreshed.
When each FDA source behind these statistics was last refreshed
Records
Last refreshed
Source as of
Status
Compliance actions (FDA Data Dashboard)
Nov 2, 2026
Newest record Oct 29, 2026
Current
Form 483 citations (FDA Data Dashboard)
Nov 16, 2026
Newest record Nov 5, 2026
Current
Compliance Actions by Type
Action type
Actions
Warning Letter
177,426
Injunction
205
Seizure
66
Year-over-Year Trends
Fiscal year
Actions
FY2027
532
FY2026
11,030
FY2025
12,186
FY2024
13,382
FY2023
14,854
FY2022
17,358
FY2021
2,513
FY2020
5,537
FY2019
15,118
FY2018
14,498
FY2017
15,337
FY2016
14,606
FY2015
17,256
FY2014
8,815
FY2013
6,793
FY2012
4,916
FY2011
1,776
FY2010
694
FY2009
496
Top Companies: Compliance Actions
Company
Actions
7-Eleven
2,487
Shell
1,814
Bp
1,659
Marathon
1,610
Circle K
1,577
Dollar General
1,514
Family Dollar
1,421
Sunoco
1,326
Mobil
967
Citgo
897
Exxon
859
Chevron
762
Speedway
746
Shell / Food Mart
702
Valero
606
Casey General Store
603
Walgreens
525
Phillips 66
441
Mobil Mart
433
Chevron / Food Mart
375
Geographic Distribution
State
Actions
Florida
17,736
New Jersey
8,450
New York
8,254
Washington
7,159
Texas
7,130
Michigan
7,095
Illinois
6,591
Ohio
6,512
Pennsylvania
6,373
Missouri
6,278
South Carolina
5,644
Massachusetts
4,902
Louisiana
4,753
North Carolina
4,607
Connecticut
4,530
Product Type Breakdown
Product type
Actions
Tobacco
168,206
Food/Cosmetics
3,742
Drugs
2,824
Devices
1,783
Veterinary
914
Biologics
228
FDA Center Breakdown
Center
Actions
CTP
168,206
CFSAN
3,742
CDER
2,824
CDRH
1,783
CVM
914
CBER
228
Most Common 483 Observations
CFR section
Description
Citations
21 CFR 1.502(a)
Maintain, follow FSVP
4,891
21 CFR 123.6(b)
No HACCP plan
4,809
21 CFR 110.35(a)
Cleaning and sanitizing operations
4,593
21 CFR 123.11(b)
Sanitation monitoring documentation
4,493
21 CFR 820.100(a)
Lack of or inadequate procedures
4,331
21 CFR 820.198(a)
Lack of or inadequate complaint procedures
3,906
21 CFR 110.35(c)
Lack of effective pest exclusion
3,734
FDCA 402(a)(4)
System for administration of drugs
3,651
21 CFR 110.20(b)(4)
Spacing of equipment
3,141
21 CFR 211.192
Written record of investigation incomplete
2,811
Form 483 Citations by Fiscal Year
Fiscal year
Citations
FY2027
198
FY2026
11,713
FY2025
14,052
FY2024
11,796
FY2023
12,114
FY2022
11,075
FY2021
6,628
FY2020
7,836
FY2019
14,915
FY2018
15,703
FY2017
17,859
FY2016
16,572
FY2015
17,623
FY2014
18,394
FY2013
19,442
FY2012
23,487
FY2011
25,722
FY2010
21,684
FY2009
16,591
Top Companies: 483 Citations
Company
Citations
Biomat Usa
273
Gate Gourmet
250
Lsg Sky Chefs
249
Flying Food Group
247
Airgas Usa
232
Baxter Healthcare Corporation
179
Central Admixture Pharmacy Services
170
Southwest Airlines
168
American Airlines
136
Vitalant
132
Loading compliance statistics…
—
Total Compliance Actions
—
Warning Letters
—
Form 483 Citations
—
Most-Cited CFR Part
Overview
A high-level snapshot of FDA compliance and enforcement activity, including warning letters,
seizures, injunctions, prosecutions, and consent decrees.
Compliance Actions by Type
The FDA takes several types of enforcement actions against companies that violate regulations.
Warning Letters are the most common, serving as formal notice of significant violations.
Seizures, injunctions, and prosecutions represent
escalating levels of enforcement.
Show data table
Year-over-Year Trends
Compliance action counts by fiscal year, broken down by action type. Trends in warning letter
volume often reflect shifts in FDA enforcement priorities and resource allocation.
Show data table
Top Companies — Compliance Actions
The 20 companies with the most FDA compliance actions, including warning letters, seizures,
injunctions, and prosecutions across all product types.
Geographic Distribution
Top 15 U.S. states by number of compliance actions. States with large pharmaceutical
and medical device manufacturing footprints tend to receive the most enforcement activity.
Show data table
Product Type & Center Breakdown
How compliance actions are distributed across FDA product categories and regulatory centers.
By Product Type
By FDA Center
Form 483 Citations — Overview
FDA Form 483 is issued to a company at the conclusion of an inspection when investigators
have observed conditions that may constitute violations of the Food Drug and Cosmetic Act.
Each citation references a specific CFR (Code of Federal Regulations) section.
Show data table
Most Common 483 Observations
The most frequently cited CFR parts on Form 483 observations. These represent the
regulatory areas where FDA inspectors most commonly find deficiencies.
Show data table
#
CFR Part
Description
Citations
Top Companies — 483 Citations
The 10 companies receiving the most Form 483 citations. A high citation count
often correlates with large manufacturing footprints and frequent FDA inspections.
Frequently Asked Questions
How many FDA warning letters are issued per year?
Loading…
What is a Form 483?
FDA Form 483 is a document issued by FDA investigators at the conclusion of an
inspection when they have observed conditions that, in their judgment, may constitute
violations of the Food Drug and Cosmetic Act and related regulations. It lists specific
observations of objectionable conditions or practices. Companies typically have 15
business days to respond with corrective actions. A Form 483 is not a final FDA
determination of violation — it is a notice of observations that may warrant further action.
What are the most common 483 observations?
Loading…
What happens after a warning letter?
After receiving a warning letter, a company is expected to respond within 15 working days
with a plan to correct the cited violations. If the company fails to adequately address
the issues, the FDA may escalate enforcement through seizures (physically taking
violative products), injunctions (court orders to stop specific practices), consent decrees
(legally binding agreements to take corrective action), or criminal prosecution in the most
serious cases. The FDA publishes all warning letters on its website and tracks compliance
responses.
Access manufacturing and compliance data programmatically through the full
FDA MCP toolset. Start free with 50 credits at signup, then 300 credits a month
after you verify your email.
Source: RegDataLab, aggregating FDA Compliance Dashboard
and FDA Inspections databases. Updated regularly from official FDA sources. This page pulls live data from our
Postgres warehouse via the /api/stats/compliance endpoint.